Skip To Content Go To Footer
Loading

Please enter at least 3 characters

Header Logo
Create Account Login
Loading

Please enter at least 3 characters

  • Science Center
  • Professional Development
  • Practice Resources
  • Events
  • About us
  • SCIENCE • DIGEST​
Create Account Login
  • Account parameters
  • Contact Us
  • Log out
Newsletter Popup
Sign up to our Newsletter
  1. Home
  2. AAD 2026 – Pigmentation Posters Overview
  • EFFICACY AND TOLERABILITY OF A 2-MNG-CONTAINING SERUM IN THE TREATMENT OF FACIAL SOLAR ENTIGO OVER 3 MONTHSOF DAILY APPLICATIONS

    Jun. 2026• International Content
  • EFFICACY AND TOLERABILITY OF A NEW 2-MNG-CONTAINING SERUM IN THE TREATMENT OF MELASMA AND POST-INFLAMMATORY HYPERPIGMENTATION IN A POPULATION FROM BRAZIL

    Apr. 2026• International Content
  • A randomized, placebo-controlled study evaluating the efficacy of a dermocosmetic serum containing 2-Mercaptonicotinyl Glycine (2-MNG) in acne-induced post-inflammatory hyperpigmentation

    Mar. 2026• International Content
  • A novel dermocosmetic routine containing Vitamin B3 and 2-Mercaptonicotinyl Glycine significantly improves melasma after 3 months of daily use and provides a similar treatment outcome after 6 months compared to a 3-month treatment course following a switch from a 3-month treatment with a Kligman triple formula

    Mar. 2026• International Content

Professional Development

  • Continuing Medical Education
  • Training

Practice Resources

  • Professional resources
  • Patient resources

Events

  • Events Reports

About us

  • Who are we?
  • What we care about
  • Contact us

Our Brands

  • La Roche-Posay
  • Vichy
  • CeraVe
  • Skinceuticals
  • SkinAlliance

Settings

  • Cookie Settings
  • Terms and Conditions
  • Privacy Policy
Country
Footer Logo